Last updated: 31 May 2024 at 5:54pm EST

John Young Net Worth




The estimated Net Worth of John D Young is at least $18.2 Million dollars as of 8 March 2023. Mr. Young owns over 1,372 units of Pfizer stock worth over $327,179 and over the last 12 years he sold PFE stock worth over $8,944,989. In addition, he makes $8,959,380 as Chief Business Officer and Group President at Pfizer.

Mr. Young PFE stock SEC Form 4 insiders trading

John has made over 23 trades of the Pfizer stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 1,372 units of PFE stock worth $87,067 on 8 March 2023.

The largest trade he's ever made was exercising 163,334 units of Pfizer stock on 25 February 2021 worth over $3,738,715. On average, John trades about 6,526 units every 16 days since 2012. As of 8 March 2023 he still owns at least 11,031 units of Pfizer stock.

You can see the complete history of Mr. Young stock trades at the bottom of the page.





John Young biography

John D. Young serves as Chief Business Officer, Group President of the Company. Primary Care Business Unit’s Regional President for Europe and Canada from 2009 until June 2012. Director of Johnson Controls International plc. Mr. Young represents Pfizer as a member of the Board of Directors of the GSK Consumer Healthcare joint venture.

What is the salary of John Young?

As the Chief Business Officer and Group President of Pfizer, the total compensation of John Young at Pfizer is $8,959,380. There are 3 executives at Pfizer getting paid more, with Albert Bourla having the highest compensation of $17,929,000.



How old is John Young?

John Young is 55, he's been the Chief Business Officer and Group President of Pfizer since 2019. There are 19 older and 7 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.

What's John Young's mailing address?

John's mailing address filed with the SEC is C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN, CT, 06511.

Insiders trading at Pfizer

Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, and James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.



What does Pfizer do?

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.



Complete history of Mr. Young stock trades at Johnson Controls International plc, Pfizer, and Arvinas Inc

Insider
Trans.
Transaction
Total value
John D Young
Director
Option $87,067
8 Mar 2023
John D Young
Group President
Sale $7,509,000
11 Nov 2021
John D Young
Group President
Option $2,892,515
27 Feb 2021
John D Young
Group President
Option $3,738,715
25 Feb 2021
John D Young
Group President
Option $2,751,999
28 Feb 2020
John D Young
Group President
Option $5,013,060
26 Feb 2020
John D Young
Group President
Option $4,975,474
27 Feb 2019
John D Young
Group President
Option $919,516
23 Feb 2019
John D Young
Group President
Option $3,315,739
28 Feb 2018
John D Young
Group President
Option $822,528
24 Feb 2018
John D Young
Group President
Option $1,084,685
23 Feb 2017
John D Young
Group President
Option $1,084,685
23 Feb 2017
John D Young
Group President
Option $1,078,779
10 May 2016
John D Young
Group President
Option $993,573
24 Feb 2016
John D Young
Group President
Option $825,300
14 Dec 2015
John D Young
Group President
Option $873,249
25 Feb 2015
John D Young
Group President
Option $486,892
31 Dec 2014
John D Young
Group President
Option $565,920
7 Nov 2014
John D Young
Group President
Sale $282,420
14 Mar 2014
John D Young
Group President
Option $731,342
26 Feb 2014
John D Young
Group President
Sale $413,877
6 Mar 2013
John D Young
Group President
Option $605,941
28 Feb 2013
John D Young
Group President
Sale $739,693
30 Jan 2013


Pfizer executives and stock owners

Pfizer executives and other stock owners filed with the SEC include: